March 12, 2020 / 7:12 AM / a month ago

BRIEF-Biovica International Q3 Operating Loss Widens To SEK 7.4 Million

March 12 (Reuters) - Biovica International AB:

* BIOVICA INTERNATIONAL AB - Q3 NET SALES SEK 55,000 VERSUS SEK 0.3 MILLION YEAR AGO

* BIOVICA INTERNATIONAL AB - Q3 OPERATING LOSS SEK 7.4 MILLION VERSUS LOSS SEK 5.8 MILLION YEAR AGO

* BIOVICA INTERNATIONAL AB - SUBMISSION OF OUR 510(K) APPLICATION FOR DIVITUM® TO FDA IS EXPECTED TO OCCUR DURING Q3 OF 2020, RATHER THAN IN MID-2020, AS EARLIER ANNOUNCED. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below